These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6721733)

  • 1. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?
    Bareggi SR; Franceschi M; Bonini L; Zecca L; Smirne S
    Arch Neurol; 1982 Nov; 39(11):709-12. PubMed ID: 6181768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
    Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF monoamine metabolites in old age dementias.
    Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
    Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
    Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
    Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory examinations correlated with severity of dementia.
    Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
    Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA.
    Airaksinen EM; Leino E
    Acta Neurol Scand; 1982 Dec; 66(6):666-72. PubMed ID: 6187174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
    Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
    Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
    Argentiero V; Tavolato B
    J Neurol; 1980; 224(1):53-8. PubMed ID: 6157799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 16. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementias, psychological tests, and neurotransmitters.
    Degrell I; Pék G; Nagy D; Nagy E; Hoyer S
    Arch Gerontol Geriatr; 1985 Dec; 4(4):365-71. PubMed ID: 2421656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF.
    Yamamoto M; Otsuki S; Kuroda H; Ogawa N
    Acta Neurol Scand; 1983 Feb; 67(2):124-7. PubMed ID: 6189358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.
    Tohgi H; Ueno M; Abe T; Takahashi S; Nozaki Y
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):69-77. PubMed ID: 1540305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.
    Lee S; Chiba T; Kitahama T; Kaieda R; Hagiwara M; Nagazumi A; Terashi A
    J Neural Transm Suppl; 1990; 30():45-55. PubMed ID: 1697333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.